US FDA accepts MS drug Lemtrada resubmission for review
US FDA accepts MS drug Lemtrada resubmission for review
The US Food and Drug Administration (FDA) has accepted for review the Genzyme's resubmission of supplemental Biologics License Application (sBLA) seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis. A six-month review period has been assigned for the Lemtrada sBLA. Genzyme expects FDA action on the sBLA in the fourth quarter...... Read More - http://www.ms-uk.org/lemtrada
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1776 Views
-
Last post by frodo
-
- 0 Replies
- 1598 Views
-
Last post by frodo
-
- 1 Replies
- 1511 Views
-
Last post by frodo
-
- 0 Replies
- 1871 Views
-
Last post by NHE
-
- 0 Replies
- 1125 Views
-
Last post by NHE
-
- 0 Replies
- 1114 Views
-
Last post by frodo
-
- 0 Replies
- 971 Views
-
Last post by frodo
-
- 0 Replies
- 1669 Views
-
Last post by frodo
-
- 0 Replies
- 2146 Views
-
Last post by NHE